Hints and tips:
...A recent survey by the Kaiser Family Foundation showed almost a third of parents would “definitely” not get their kids vaccinated....
...The BioNTech/Pfizer jab will be dispensed in “kid-sized” doses, a third of the size of those for people aged 12 years and more....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...Ahead of a crucial meeting of the Food and Drug Administration vaccines advisory committee on Friday to discuss its booster proposal, Pfizer on Wednesday submitted a study by Kaiser Permanente Southern California...
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...Liz Hamel, who directs polling at the Kaiser Family Foundation health think-tank, said: “We know that side effects are people’s biggest concern about the vaccine....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...The three leading companies count 71 per cent of Medicare patients enrolled in prescription drug plans as their customers, according to the Kaiser Family Foundation, a healthcare research institution....
...(NYT, New Statesman) Dementia drug blow The difficulty of finding drugs to treat Alzheimer's and Parkinson's diseases was underlined by Pfizer's withdrawal from research....
...Shares of large drugmakers also tumbled, as investors fretted they would struggle to maintain premium prices, with Pfizer, AbbVie and Merck losing between 1.6 per cent and 5.3 per cent....
...(Stat) UK life sciences laggard A report for pharma giant Pfizer says Britain is falling behind in the prescription of new medicines, despite its prowess in science and a skilled workforce....
...(FT, The Lancet) Depression test questioned Campaigners say doctors could be misdiagnosing depression by being too reliant on a questionnaire devised by Pfizer — a maker of antidepressant drugs....
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
...A survey released this week by the Kaiser Family Foundation, a US think tank, shows disbursement for Aids from international donors already slipping, from $7.7bn in 2008 to $7.6bn in 2009, after a sixfold...
...But the parallel interrelated lives of Kaiser Wilhelm II, George V and Nicholas II are more than that....
...Last week’s US jobs report has knocked investor confidence, and those predicting a V-shaped recovery are finding it harder to justify their positions....
...This spurred groups such as Pfizer of the US and Roche of Switzerland to strike multi-billion-dollar deals during the first half of this year....
...Kindler, Chairman and CEO, Pfizer Inc., USA Klaus Kleinfeld, President and CEO, Siemens AG, Germany Mustafa V....
...He was born in 1954, the year, as he points out, of the famous Brown v Board of Education case which paved the way for US desegregation....
International Edition